Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2010
12/09/2010US20100311081 Predicting cancer progression
12/09/2010US20100311080 Water-soluble nanocrystals through dual-interaction ligands
12/09/2010US20100311079 Assay for cardiac troponin autoantibodies
12/09/2010US20100311078 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
12/09/2010US20100311077 Use of GPR100 Receptor in Diabetes and Obesity Regulation
12/09/2010US20100311076 Method of binding proteins to carriers by making use of tamavidins
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100311074 Switch-region: target and method for inhibition of bacterial rna polymerase
12/09/2010US20100311072 Fluorescence polarization binding assay for characterizing glucokinase ligands
12/09/2010US20100311071 Compositions and Methods for Detecting Juvenile Renal Dysplasia or Calcium Oxalate Stones in Dogs
12/09/2010US20100311068 Assay
12/09/2010US20100311066 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
12/09/2010US20100311065 Genetically modified microbes producing isoprenoids
12/09/2010US20100311064 Multiplex nucleic acid reactions
12/09/2010US20100311054 Compositions and Methods for the Detection of Human T Cell Receptor Variable Family Gene Expression
12/09/2010US20100311053 Use of clec1b for the determination of cardiovascular and thrombotic risk
12/09/2010US20100311051 Calcium-binding photoprotein, gene encoding the same and use thereof
12/09/2010US20100311050 Compositions and methods for the diagnosis and treatment of tumor
12/09/2010US20100311047 Identification Of Cancer Protein Biomarkers Using Proteomic Techniques
12/09/2010US20100311045 Cancer
12/09/2010US20100311043 RNA complexes, method of their production and sensors and analytical methods involving same
12/09/2010US20100311039 Non-target amplification method for detection of rna splice-forms in a sample
12/09/2010US20100310773 Fine Metal Structure, Process for Producing the Same, Fine Metal Mold and Device
12/09/2010US20100310644 Anti-dandruff compositions containing peptides
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310597 Anti-ofloxacin monoclonal antibody and immunoassay of ofloxacin using the same
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310574 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
12/09/2010US20100310573 Anti-cd4 antibody
12/09/2010US20100310572 Binding molecules capable of neutralizing rabies virus and uses thereof
12/09/2010US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
12/09/2010US20100310568 Ninjurin-1 modulation and uses thereof
12/09/2010US20100310559 Bind to human colorectal and pancreatic carcinoma-associated antigens (CPAA), diagnostics, vaccines; kits
12/09/2010US20100310557 Antibodies immunoreactive with heregulin-coupled her3
12/09/2010US20100310553 Compositions and Methods for Controlling Hepatitis C Virus Infection
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310543 Method of preventing and treating acute brain pathologies
12/09/2010US20100310540 Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds
12/09/2010US20100310539 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials
12/09/2010US20100310534 T cell subpopulations capable of treating cancer
12/09/2010US20100310532 Gene targets in anti-aging therapy and tissue repair
12/09/2010US20100310525 Wnt pathway stimulation in reprogramming somatic cells
12/09/2010US20100310511 Determining disease or immune system features based on analysis of immune system characteristics
12/09/2010US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1
12/09/2010US20100310507 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/09/2010US20100310472 Dna sequence, and recombinant preparation of the grass pollen allergen lol p 4
12/09/2010US20100310464 Antibodies
12/09/2010US20100310463 Anti-EpCAM Antibodies
12/09/2010US20100310462 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010US20100310458 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
12/09/2010US20100310452 Prostate-specific membrane antigen and uses thereof
12/09/2010US20100310451 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
12/09/2010US20100310450 method of diagnosis and agents useful for same
12/09/2010US20100310422 Optical biosensor
12/09/2010US20100310420 Sensors
12/09/2010US20100310419 Method for supplying gas mixtures for an analyzer
12/09/2010US20100309454 Spectrometers miniaturized for working with cellular phones and other portable electronic devices
12/09/2010US20100309001 Method and System for Transferring Analyte Test Data
12/09/2010US20100308275 Inorganic particle conjugates
12/09/2010US20100308272 Monodisperse Core/Shell and Other Complex Structured Nanocrystals and Methods of Preparing the Same
12/09/2010US20100307929 Sensor and method for measuring amount of analyte in human interstitial fluid, fluid channel unit
12/09/2010US20100307258 Method and apparatus for the non-destructive measurement of the compressive strength of a solid
12/09/2010US20100307230 Method and system for monitoring the state of an engine oil in an internal combustion engine
12/09/2010DE202009014555U1 Atem-Alkoholkontrolle mit Wegfahrsperre Breath alcohol control with immobilizer
12/09/2010DE112008002874T5 Mehrschichtgassensor mit zwei Heizzonen Multilayer gas sensor with two heating zones
12/09/2010DE102010011671A1 Bestimmung des Endes der Lebensdauer von Öl durch elektrisches Mittel Determining the end of life of oil through electrical means
12/09/2010DE102009026453A1 Verfahren und Vorrichtung zur Bestimmung einer Aussage über das Vorkommen von Inhaltsstoffen einer flüssigen Probe mit Sauerstoffbedarf Method and apparatus for determining information about the presence of ingredients of a liquid sample with oxygen demand
12/09/2010DE102009023430A1 Vorrichtung und Verfahren zum Steuern von Fluidströmen in Lab-on-a-Chip-Systemen sowie Verfahren zum Herstellen der Vorrichtung Apparatus and method for controlling fluid flows in lab-on-a-chip systems, and methods for manufacturing the device
12/09/2010DE102009022814A1 Equipment arrangement for analyzing e.g. gaseous test specimen, has sensor modules attached to sample line and comprising evaluation electronics that transforms electrical signals into digital signals
12/09/2010DE102009017932B4 Verfahren zur kontinuierlichen quantitativen Bestimmung einer oxidierbaren chemischen Verbindung in einem Untersuchungsmedium Process for the continuous quantitative determination of an oxidizable chemical compound in an assay medium
12/09/2010DE102007054909B4 Vorrichtung und Verfahren zur Ausrichtung eines tablettenförmigen Prüflings Apparatus and method for aligning a tablet-like sample
12/09/2010DE102006055331B4 Probenträger und Probenspeicher zur Kryokonservierung biologischer Proben Sample holder and sample storage for cryopreservation of biological samples
12/09/2010CA2769999A1 A cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
12/09/2010CA2764670A1 Methods, reagents and kits for flow cytometric immunophenotyping
12/09/2010CA2764346A1 Non invasive gas analysis
12/09/2010CA2764337A1 Combination of breathalyser and electrochemical saliva drug test
12/09/2010CA2764321A1 Novel strains of helicobacter pylori and uses thereof
12/09/2010CA2764237A1 Ensuring sample adequacy using turbidity light scattering techniques
12/09/2010CA2764198A1 Device and method for determining the composition of a mixture of fluids
12/09/2010CA2764153A1 Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
12/09/2010CA2764049A1 Means and methods for diagnosing prostate carcinomas
12/09/2010CA2763948A1 Combination of amino acids, acylcarnitines and biogenic amines for the assessment of chronic kidney disease
12/09/2010CA2763838A1 Immunologic tests and kits
12/09/2010CA2763164A1 Methods of modulating fucosylation of glycoproteins
12/09/2010CA2763075A1 Recombinantly produced allergens
12/09/2010CA2762277A1 Specific analysis of ketone and aldehyde analytes using reagent compounds labeling strategies, and mass spectrometry workflow
12/09/2010CA2761733A1 Reagents and methods for detecting influenza virus proteins
12/08/2010EP2259070A2 Container
12/08/2010EP2259069A1 Blood coagulation analyzer, method of analyzing blood coagulation and computer program
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2259067A2 Methods for immunolabeling
12/08/2010EP2259066A1 Reagents for HCV antigen-antibody combination assays
12/08/2010EP2259065A1 Methods, reagents and kits for flow cytometric immunophenotyping
12/08/2010EP2259064A2 Peptide compounds for detecting or inhibiting SARS coronavirus and application thereof
12/08/2010EP2259063A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
12/08/2010EP2259062A2 Biosensor apparatus and methods of use
12/08/2010EP2259061A2 Boronic acid derivatives
12/08/2010EP2259060A1 High-molecular-weight adiponectin measurement method
12/08/2010EP2259059A1 Means and methods for ovarian cancer prognosis
12/08/2010EP2259058A1 Method of measuring hematocrit value or blood component concentration and measurement system